Complement Component C5a Antibody (241) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-89579IR
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 241
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Complement Component C5a Antibody (241) [DyLight 755]
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human Complement Component C5a (Accession#: NP_001726.2; Leu679-Arg751).
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Complement Component C5a Antibody (241) [DyLight 755]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Complement Component C5a
Alternate Names
C5, C5A, HE
Gene Symbol
C5
Additional Complement Component C5a Products
Product Documents for Complement Component C5a Antibody (241) [DyLight 755]
Product Specific Notices for Complement Component C5a Antibody (241) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...